NIKKEI 225
27,327.11 -106.29 (-0.39%) HANG SENG
21,842.33 -227.40 (-1.03%) CRUDE OIL
78.58 +0.68 (+0.87%) GOLD FUTURES
1,944.20 +5.00 (+0.26%) DOW
33,795.31 +78.22 (+0.23%) BTC-GBP
18,765.39 -160.48 (-0.85%)
Sanofi (SAN.PA)
| Previous close | 89.79 |
| Open | 89.77 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 89.02 - 90.62 |
| 52-week range | 76.45 - 106.66 |
| Volume | |
| Avg. volume | 1,751,240 |
| Market cap | 112.324B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 17.58 |
| EPS (TTM) | 5.10 |
| Earnings date | 03 Feb 2023 |
| Forward dividend & yield | 3.33 (3.71%) |
| Ex-dividend date | 06 May 2022 |
| 1y target est | 102.70 |
- Bloomberg
Advil Maker Haleon Said to Study Potential Deals to Bulk Up
(Bloomberg) -- Haleon Plc, the consumer health business spun out from British pharmaceutical producer GSK Plc, is in the early stages of studying large potential deals to bulk up its brand portfolio, people with knowledge of the matter said. Most Read from BloombergSony Slashes PlayStation VR2 Headset Output After Pre-Orders DisappointTrump Sues Journalist Bob Woodward for Releasing Interview RecordingsWall Street Is Losing Out to Amateur Buyers in the Housing SlumpBrexit Is Costing the UK £100
- Zacks
Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough Tag
Moderna (MRNA) announces that the FDA granted Breakthrough Therapy Designation to its respiratory syncytial virus (RSV) vaccine candidate, mRNA-1345 for the prevention of respiratory disease in older adults.
- Zacks
Can Sanofi (SNY) Keep the Beat Streak Alive in Q4 Earnings?
Sanofi's (SNY) top line is likely to have been driven by higher sales of Dupixent and vaccines.
